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(between 1 and 10 DRGs). In 6 of the countries more than half 
of the patients are concentrated within a single DRG. The 
countries’ systems also vary with respect to the evaluation of 
different kinds of stroke patients. The most complex DRG is 
considered 3.8 times more resource intensive than an index 
case in Finland. By contrast, in England, the DRG system does 
not account for complex cases. Comparisons of quasi prices 
for the case vignettes show that hypothetical payments for 
the index case amount to only EUR 907 in Poland but to EUR 
7,881 in Ireland.  Conclusions: Large variations in the classifi-
cation of stroke patients raise concerns whether all systems 
rely on the most appropriate classification variables and 
whether the DRGs adequately reflect differences in the com-
plexity of treating different groups of patients. Learning 
from other DRG systems may help in improving the national 
systems. Clinicians and national DRG authorities should con-
sider how other countries’ DRG systems classify stroke pa-
tients in order to optimize their DRG system and to ensure 
fair and appropriate reimbursement. In future, quantitative 
research is needed to verify whether the most important de-
terminants of cost are considered in different patient classi-
fication systems, and whether differences between systems 
reflect country-specific differences in treatment patterns 
and, most importantly, what influence they have on patient 
outcomes.  Copyright © 2013 S. Karger AG, Basel 
 Key Words 
 Acute stroke · Diagnosis-related groups · Europe · 
Hospital financing · Cerebral infarct 
 Abstract 
 Background: Diagnosis-related groups (DRGs) are increas-
ingly being used for various purposes in many countries. 
However, there are no studies comparing different DRG sys-
tems in the care of stroke. As part of the EuroDRG project, 
researchers from 11 countries (i.e. Austria, England, Estonia, 
Finland, France, Germany, Ireland, the Netherlands, Poland, 
Sweden and Spain) compared how their DRG systems deal 
with stroke patients. The study aims to assist clinicians and 
national authorities to optimize their DRG systems.  Meth-
ods: National or regional databases were used to identify 
hospital cases with a diagnosis of stroke. DRG classification 
algorithms and indicators of resource consumption were 
compared for those DRGs that individually represent at least 
1% of stroke cases. In addition, standardized case vignettes 
were defined, and quasi prices according to national DRG-
based hospital payment systems were ascertained.  Results: 
European DRG systems vary widely: they classify stroke pa-
tients according to different sets of variables (between 1 and 
7 classification variables) into diverging numbers of DRGs 
 Received: June 7, 2012 
 Accepted: November 22, 2012 
 Published online: February 7, 2013 
 Mikko Peltola 
 Centre for Health and Social Economics
National Institute for Health and Welfare ,  Mannerheimintie 166 
 FI–00270 Helsinki (Finland) 
 E-Mail mikko.peltola   @   thl.fi 
 © 2013 S. Karger AG, Basel
1015–9770/13/0352–0113$38.00/0 
 Accessible online at:
www.karger.com/ced 
D
ow
nl
oa
de
d 
by
: 
Te
ch
ni
sc
he
 U
ni
ve
rs
itä
t B
er
lin
   
   
   
   
   
   
   
   
  
13
0.
14
9.
13
4.
29
 - 
10
/2
5/
20
17
 5
:4
0:
20
 P
M
 Peltola/Quentin 
 
 Cerebrovasc Dis 2013;35:113–123
DOI: 10.1159/000346092
114
 Introduction 
 Diagnosis-related groups (DRGs) are used in Europe 
for a range of different purposes: they form the basis of 
hospital performance comparisons, they are used to fa-
cilitate hospital management, and in current DRG-
based hospital payment systems, DRGs define the pay-
ment categories, i.e. hospital products  [1, 2] . DRGs are 
‘diagnosis-related’ groups of patients that have (a) simi-
lar resource consumption patterns and that are (b) clin-
ically meaningful  [3] . They are defined by patient clas-
sification systems – i.e. DRG systems – which group 
treatment cases into DRGs on the basis of classification 
variables such as diagnoses, procedures and demo-
graphic characteristics.
 It is very important that DRGs are sufficiently homog-
enous in terms of treatment costs. Otherwise, DRG-based 
performance comparisons do not adequately control for 
differences of patients within groups; and reimbursement 
for a large number of patients is not appropriate. In order 
to assure homogenous groups of patients, DRG systems 
need to consider the most important determinants of re-
source consumption as classification variables. In many 
countries, professional medical associations, specialist 
experts or consultants formally participate in the process 
of selection, definition and update of classification crite-
ria via committees, expert hearings or consultations  [4–
6] . It is, therefore, of the utmost importance for specialist 
groups such as neurologists that they are aware of how 
their respective patients are classified into DRGs in order 
to assess whether current classification variables ade-
quately reflect differences in the complexity of treating 
different groups of patients. Learning from other DRG 
systems may help in improving the national systems.
 This study performs a comprehensive assessment of 
DRG systems across 11 European countries and has 3 
main objectives: (1) to assess classification variables and 
algorithms used to group patients with stroke into DRGs; 
(2) to compare variations in DRG weights, and (3) to de-
termine DRGs and hospital price levels for 6 case vi-
gnettes of stroke patients with different combinations of 
diagnostic and treatment variables.
 Materials and Methods 
 Definition of Episode of Care and Stroke Index Case 
 Similar methods have been reported previously for another ep-
isode of care  [7] . As part of the EuroDRG project, researchers from 
11 countries (i.e. Austria, England, Estonia, Finland, France, Ger-
many, Ireland, the Netherlands, Poland, Sweden and Spain) agreed 
upon a common definition for a stroke episode of care. The defini-
tion requires a diagnosis of stroke in the International Classifica-
tion of Diseases, 10th edition (ICD-10), and is presented in  table 1 . 
A stroke index case was defined to facilitate comparisons of rela-
tive resource intensity of DRGs within countries ( table 1 ). The in-
dex case is characterized by the most common patient and treat-
ment characteristics of uncomplicated stroke cases in hospitals of 
the selected countries: a 78-year-old patient without complica-
tions, no major procedures, discharged alive, and treated as inpa-
tient.
 Data Sources 
 In each country, researchers identified national or regional 
hospital databases and obtained access to all information necessary 
for the purposes of this study. The number of stroke cases con-
forming to our definition and the corresponding DRGs were ex-
tracted from the databases.  Table 2 provides an overview of the 
databases and data years available. No ethical permissions were 
required for this analysis.
 Analysis of Patient Classification Systems 
 Detailed comparative analyses of classification variables and 
grouping algorithms of national DRG systems  [8–16] were per-
formed for the most frequent DRGs, i.e. those DRGs that indi-
vidually represented at least 1% of stroke cases in the relevant 
database. Grouping algorithms were mapped graphically to fa-
cilitate comparisons between systems ( fig. 1 a, b). In addition, the 
percentage of all stroke cases grouped into each DRG was calcu-
lated. In order to compare DRG weights (i.e. relative weights, 
scores, tariffs) within and across countries, a DRG weight index 
was calculated with the index case ( table 1 ) assuming a value of 
1. The index score of all other DRGs was calculated by dividing 
the national measure of DRG weight of each DRG by that of the 
index DRG.
 DRGs and Hospital Quasi Prices 
 In addition to the index case, 6 stroke cases with different com-
binations of primary and secondary diagnoses, procedures, length 
of stay, and stroke unit care were defined ( table 3 ). Case vignettes 
were selected specifically to illustrate differences in DRG systems 
across countries, i.e. only patient and treatment characteristics 
were specified that are relevant for the classification of patients and 
reimbursement of hospitals in at least one country but not in all 
Table 1.  Definition of the episode of care and the index case
Definition  
Name Stroke
Defined by Primary diagnosis
Primary diagnosis I61 – intracerebral haemorrhage
I63 – cerebral infarction
I64 – stroke, not specified as haemor-
rhage or infarction
 
Index case  
Female, age 78 years, cerebral infarction without complicat-
ing secondary diagnoses, no major procedures, treated as 
inpatient, no death during the hospital stay
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other countries. Case vignettes 1–4 are patients suffering from ce-
rebral infarction. Case vignettes 5 and 6 are patients with intrace-
rebral haemorrhage.
 DRG-based hospital payment systems differ between and often 
even within countries, thus complicating comparisons. Therefore, 
quasi prices were ascertained for each case vignette and for the in-
dex case using an approach similar to that of Koechlin et al.  [17] . 
Quasi prices were calculated by converting national measures of 
DRG weight (i.e. cost weights, average tariffs, scores – taking ac-
count of outlier deduction/add-ons or additional payments where 
possible) into monetary values using national conversion rates. If 
necessary, prices were deflated to year 2008 national currency us-
ing national gross domestic product deflators  [18] , and converted 
to euros using average currency exchange rates for the year 2008 
 [19] . In addition, a quasi price index was calculated with the index 
case assuming a value of 1. The index score of all other case vi-
gnettes was calculated by dividing the value of the quasi price of 
each case vignette by that of the index case.
 Results 
 Figure 1 a and b provides a graphic illustration of 
grouping algorithms and classification variables of DRG 
systems in 11 European countries. The figures include 
classification variables of those DRGs that individually 
represent at least 1% of stroke cases in each country. 
DRGs containing less than 1% of cases in the national da-
tabase but essential for understanding the grouping logic 
are shaded in light grey and are not considered in the fol-
lowing analysis. The index DRGs are highlighted in dark 
grey. On the left-hand side, the figures specify for each 
country the version of the DRG system and the percent-
age of all identified stroke cases that are shown in the 
graph. The two last columns on the right show the per-
centage of stroke cases covered by each DRG and the 
DRG weight index.
 Overview: Number of DRGs, Number of Classification 
Variables 
 The figures demonstrate that there is great variation in 
DRG systems across Europe. The percentage of all stroke 
cases covered by the DRGs included in our analysis rang-
es from 90% in Germany to 100% in the Netherlands. In 
Estonia, almost all stroke cases are classified into a single 
DRG, while in France and Germany 10 different DRGs 
with more than 1% of stroke cases exist.
 In addition, the number of classification variables var-
ies: the English system differentiates only between main 
diagnoses when classifying stroke patients. By contrast, 
the German system differentiates (1) main diagnoses, (2) 
procedures (including systemic thrombolysis, rehabilita-
tion and artificial ventilation), (3) death during admis-
sion, (4) complications (i.e. motor dysfunction), (5) 
stroke unit treatment, and (6) length of stay.
 Characteristics of Classification Variables 
 In all countries’ systems, a primary diagnosis of stroke 
is considered at an early stage in the grouping algorithm. 
However, only 6 DRG systems differentiate between pa-
tients with a primary diagnosis of cerebral infarction and 
those with a primary diagnosis of intracranial or intrace-
rebral haemorrhage.
 Similarly, the presence of relevant secondary diagno-
ses, i.e. complications and comorbidities, influences the 
Table 2.  Data years and databases by country
Country Data
year
Number 
of cases
Source of data
Austria 2008 18,092 Leistungsorientierte Krankenanstaltenfinanzierung database of the Bundesministerium für 
Gesundheit
England 2007/2008 70,256 Hospital Episode Statistics
Estonia 2008 5,729 Estonia Health Insurance Fund database
Finland 2008 13,095 Hospital Discharge Register
France 20081 96,920 Programme de Médicalisation des Systèmes d’Information en Médecine, Chirurgie, 
 Obstétrique
Germany 2008 267,592 Fallpauschalenbezogene Krankenhausstatistik (DRG statistic) of the Federal Statistical Office 
(Destatis)
Ireland 2008 5,380 Hospital Inpatient Enquiry Scheme database of the Health Services Executive
The Netherlands 2008 31,663 Diagnose Behandeling Combinaties Onderhoud database
Poland 2009 87,397 Register of episodes of care and reimbursements of the National Health Fund
Spain (Catalonia) 2008 11,089 Hospital Minimum Basic Data Set database of the Public Hospital Network of Catalonia
Sweden 2008 32,849 The National Patient Register of the Board of Health and Welfare
1 Data from 2008 were regrouped by the national DRG authority into the 2010 version of GHM (GHM version 11b).
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 Fig. 1. Graphic illustrations of algorithms and variables. LoS = 
Length of stay; EoC = episode of care; HRG = healthcare resource 
group; TIA = transient ischaemic attack; Fi = Finland; CC = com-
plications and comorbidities; Sw = Sweden; ICB = intracranial 
bleeding; ST = systemic thrombolysis; PCCL = patient clinical 
complexity level ; MDC = main diagnostic category .  a Grouping 
algorithms and classification variables of DRG systems in 6 Euro-
pean countries.  b Grouping algorithms and classification variables 
of DRG systems in 5 European countries. 
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classification of patients in the majority of countries. In 
all countries included in  figure 1 b, i.e. Austria, Germany, 
the Netherlands, Poland and Spain, patients treated with 
thrombolysis are assigned into specific groups. Other 
treatment-related classification variables include extra-
cranial or intracranial vascular procedures (Finland and 
Spain), mechanical ventilation (Ireland and Germany), 
length of stay (France, Germany, Ireland and Poland) and 
in-hospital rehabilitation (Germany).
 Provider and setting characteristics are considered by 
5 DRG systems (i.e. in Austria, Finland, Germany, the 
Netherlands and Poland). In Finland and the Nether-
lands, day case admissions are identified by the grouping 
algorithm and are assigned into specific groups. Treat-
ment in a stroke unit is used as a classification variable 
only in Austria, Germany and Poland.
 Distribution of Stroke Cases and Variation of DRG 
Weights 
 In all countries except for Sweden, the vast majority of 
stroke cases are grouped into the shadowed DRG con-
taining the index case ( fig.  1 a, b), i.e. between 31% in 
France and 98% in Estonia. In fact, in Austria, England, 
Estonia, Finland, the Netherlands and Spain, more than 
half of the patients are concentrated within a single DRG.
 In those countries, where comorbidities are taken into 
account in the grouping algorithms, DRGs for patients 
with complications have DRG weights that are much 
higher than the index DRG. Similarly, in countries where 
stroke unit treatment or systemic thrombolysis are used 
as classification variables, DRG weights for patients treat-
ed in stroke units or with thrombolysis have much higher 
DRG weights. In fact, stroke unit treatment for more than 
72 h doubles the DRG weight in Germany (G-DRG B70B), 
and increases the DRG weight by 36% in Austria 
(MEL26.02A). Systemic thrombolysis increases the DRG 
weight (compared with the index DRG) by 17% in the 
Netherlands, and more than doubles the DRG weight in 
Austria and Spain.
 DRGs and Hospital Quasi Prices for Case Vignettes 
 Table 4 shows the comparison of DRGs and hospital 
quasi prices for the index case and the 6 case vignettes 
under the assumption that hospital payment would be 
exclusively based on DRGs. For each case vignette, the 
first column specifies the DRG into which a case vignette 
patient would be classified, and the second column spec-
ifies for each patient the corresponding quasi price.
 Partially reflecting differences in terms of gross do-
mestic product per capita  [18] , the quasi price of the index 
case varies substantially across countries, ranging from 
EUR 907 in Poland to EUR 7,881 in Ireland. However, 
countries paying a higher price for one type of patient do 
not necessarily pay a higher price for all kinds of patients. 
For example, hospitals in England would receive much 
higher payments than hospitals in Germany for a patient 
with ischaemic stroke, treated with thrombolysis and dis-
charged alive after 7 days (patient 3). Conversely, hospi-
tals in Germany would receive higher payments than hos-
pitals in England for a patient with haemorrhagic stroke, 
treated in a stroke unit and discharged alive after 10 days 
(patient 6).  Figure 2 facilitates these kinds of comparisons 
Table 3.  Case vignettes: patient classification variables
Case Primary 
diagnosis
Secondary 
diagnoses
Specific procedures Sex Age
years
Setting Death during 
admission
Length
of stay
days
Stroke 
unit
Index I63.0 female 78 inpatient no 10 no
1 I63.0 female 78 day care no 0 no
2 I63.0 99.10 female 78 inpatient yes 4 no
3 I63.0 99.10 female 78 inpatient no 7 no
4 I63.0 E11.8, I48 99.10, 93.12, 93.72, 93.74 female 78 inpatient no 10 yes
5 I61.0 female 78 inpatient no 10 no
6 I61.0 E11.8, I48 93.12, 93.72, 93.74 female 78 inpatient no 10 yes
Primary and secondary diagnoses assessed by ICD-10, specific procedures by ICD9-CM. ‘Stroke unit’ concerns only Germany and 
Austria, as based on the DRG algorithms the other countries’ classification systems do not take into account the treatment unit. E11.8 
= Non-insulin-dependent diabetes mellitus with unspecified complications; I48 = atrial fibrillation and flutter; 93.12 = physical therapy 
exercises: other active musculoskeletal exercise; 93.72 = speech and reading rehabilitation and rehabilitation of the blind: dysphasia 
training; 93.74 = speech and reading rehabilitation and rehabilitation of the blind: speech defect training; 99.10 = injection or infusion 
of thrombolytic agent.
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by presenting the results of  table 4 using the quasi price 
index score, which compares hospital quasi prices within 
countries for each patient to the quasi price for the index 
case.  Figure 2 illustrates that in England, Estonia and the 
Netherlands the variation of quasi prices is very small. 
Moreover,  figure 2 shows that countries award the high-
est payments for different kinds of patients.
 Discussion 
 This is the most comprehensive available comparative 
analysis of grouping algorithms, classification variables 
and prices for stroke patients in different DRG-based 
hospital payment systems in Europe. It shows great vari-
ation across countries: (1) in the number of DRGs; (2) in 
the characteristics of classification variables; (3) in the de-
gree of differentiation between complex and less complex 
cases, and (4) in the quasi prices for different types of pa-
tients (case vignettes).
 As DRGs are used to assess the performance of hospi-
tals (including that of neurologists) and to determine hos-
pital payment  [1, 2, 20] , it is important that DRG systems 
consider the most appropriate classification variables to 
assure that performance comparisons and hospital pay-
ments are fair  [21, 22] . Given the identified large varia-
tions between DRG systems in different countries for the 
classification of stroke patients, it is at least questionable 
whether all DRG systems consider as classification vari-
ables the most important determinants of resource con-
sumption.
 Neurologists can influence decisions about classifica-
tion variables in their roles as advisors to national author-
ities responsible for defining and updating the patient 
classification systems of their countries  [4–6] . In Germa-
ny, neurologists have played an important role in the pro-
cess of optimizing the classification of stroke patients 
 [23] . International comparisons can provide a useful new 
perspective when thinking about how to improve an ex-
isting DRG system. However, before drawing conclu-
sions on the basis of this study’s findings, limitations of 
our data and methodology need to be considered.
 Firstly, our study used routine inpatient databases to 
identify patients and to assess the relative importance of 
different DRGs in different countries. As highlighted by 
the Hospital Data Project, there are differences in cod-
ing practices across countries, and the quality of data is 
not always comparable  [24] . Secondly, differences in 
hospital payment systems between countries complicate 
comparative analyses of payment levels ( table 4 ). On the 
one hand, different countries set DRG-based payment 
rates at different levels as they include different cost cat-
0
0.5
1.0
1.5
3.0
2.5
2.0
3.5
4.0
Austria England Estonia Finland France Germany Ireland The
Netherlands
Poland Spain Sweden
Case 1
Case 2
Case 3
Case 4
Case 5
Case 6
 Fig. 2. Comparison of price indices for the stroke case vignettes in 11 European countries (the price index of the 
index case equals 1.0 in each country). 
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egories. For example, in Germany, fixed capital costs are 
not included in DRG-based payment rates, while most 
other countries included this cost category in payment 
rates  [17] . On the other hand, different systems of ad-
ditional payments exist, e.g. England assigns additional 
(‘unbundled’) healthcare resource groups for certain di-
agnostic evaluations such as CT scans and for intensive 
care unit treatment (‘critical care’)  [25] , and Poland and 
Austria have additional per diem based payments for 
stays in intensive care units. Furthermore, the Nether-
lands and Finland can have several DRGs per hospital 
stay, each leading to additional DRG-based payments, 
and several countries adjust payments in order to ac-
count for differences between hospitals or regions. 
Therefore, the absolute price levels should not be direct-
ly interpreted as reflecting more expensive care in one 
country compared to another. However, relative price 
levels within countries that were used for comparisons 
in  figures 1 a, b, and  2 should be less affected by differ-
ences in payment systems or cost-accounting methods 
as they were always compared to the in-country DRG 
index case. Also, the interpretation of the relative prices 
is simple: an index score of 1.50 (in  fig. 1 a, b or  2 ) indi-
cates 50% higher compensation than is given for the in-
dex case. Thirdly, as we limit our analysis to those more 
frequent DRGs that account for at least 1% of cases in 
our databases, and to patients with more common com-
binations of diagnoses and procedures, we partially ne-
glect how different systems deal with rare outliers, which 
may, however, be particularly relevant for reimburse-
ment. Finally, our data did not allow us to identify rea-
sons for the differences in DRG systems and hospital 
payments between countries. Yet, future research could 
illuminate whether some countries intentionally did not 
include certain classification variables in their DRG sys-
tems.
 In spite of these limitations, our study has major im-
plications for neurologists and national authorities in-
volved in the redesigning of DRG systems. First, aware-
ness about classification algorithms and variables in oth-
er countries should encourage neurologists to think about 
alternative and possibly better ways to classify their pa-
tients into DRGs. For example, the treatment of stroke 
patients in dedicated stroke units has been recommended 
by European and American guidelines for the manage-
ment of stroke patients  [26, 27] . However, treatment in a 
stroke unit is more expensive than treatment on a gen-
eral medical ward  [28, 29] . At the time of our study, these 
extra costs were not adequately reimbursed in the major-
ity of countries, as the treatment of patients within the 
setting of a stroke unit was taken into account only by the 
DRG systems in Austria, Germany and Poland. Since 
then, stroke unit care has been incorporated into the ‘best 
practice tariff’ in England  [30] but – to our knowledge – 
other countries have not explicitly incorporated stroke 
unit care into their DRG-based hospital payment sys-
tems. Similarly, while most countries’ DRG-based hospi-
tal payment systems assign higher payments if treatment 
includes thrombolysis, this costly but highly effective  [31] 
and recommended  [26, 27] intervention is not taken into 
account by DRG systems in Estonia, Finland, France, Ire-
land and Sweden. Furthermore, this has not changed 
since the time of our study. Therefore, Estonia, Finland, 
France, Ireland, the Netherlands, Spain and Sweden could 
investigate whether their DRG algorithms would be im-
proved by introducing classification variables for stroke 
unit treatment or systemic thrombolysis.
 Second, numerous studies have identified stroke se-
verity to be the most important determinant of resource 
use in the treatment of stroke patients  [32–37] . However, 
stroke severity is not included as a classification variable 
in any of the DRG systems analysed. While possibilities 
exist for stratifying stroke patients according to severity 
using neuroimaging studies  [32] or the National Institute 
of Health Stroke Scale, ICD-10 codes for different sever-
ity levels of stroke do currently not exist, which would be 
a prerequisite for incorporating severity into DRG sys-
tems. By contrast, secondary diagnoses, which have also 
been found to be predictors of resource use  [32, 33, 36] 
are considered in 5 of the analysed DRG systems. How-
ever, Austria, England, Estonia, the Netherlands and Po-
land should assess whether the homogeneity of DRGs 
could be improved by incorporating secondary diagnoses 
into their classification algorithms. Possibly, in countries 
where DRGs do not take into account differences in the 
complexity of treating different groups of patients, some 
of the differences in patient populations between hospi-
tals are accounted for through the above-mentioned ad-
justments outside of the DRG systems. However, ideally, 
differences in patient characteristics would be accounted 
for in the patient classification systems and not in the pay-
ment systems.
 Third, the comparison of DRG weights and quasi pric-
es showed that hospitals in England receive higher pay-
ments for patients with ischaemic stroke than for patients 
with haemorrhagic stroke, while the opposite is true in 
Austria, Germany and Spain. Interestingly, available 
studies suggest that, in fact, treatment of haemorrhagic 
stroke when compared to ischaemic stroke is associated 
with higher cost in Germany  [38] but with lower costs in 
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